GSK106
GSK106 is an inactive control for the selective PAD4 inhibitors, GSK484 and GSK199[1].
Product Specifications
CAS Number
[1652591-82-6]
UNSPSC
12352005
Target
Protein Arginine Deiminase
Type
Reference compound
Related Pathways
Epigenetics
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/gsk106.html
Purity
98.28
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N1CC(N)CCC1)C2=CC=C3N=C(C(N4CC)=CC5=C4C=CC=C5)N(C)C3=C2.Cl
Molecular Formula
C24H28ClN5O
Molecular Weight
437.97
References & Citations
[1]Lewis HD, et al. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation. Nat Chem Biol. 2015 Mar;11 (3) :189-91.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1126944-01 0.02 mg (E-Coli)
Recombinant Mycobacterium leprae N5-carboxyaminoimidazole ribonucleotide synthase (purK)
Ask
View Details MBS1126944-02 0.02 mg (Yeast)
Recombinant Mycobacterium leprae N5-carboxyaminoimidazole ribonucleotide synthase (purK)
Ask
View Details MBS1126944-03 0.1 mg (E-Coli)
Recombinant Mycobacterium leprae N5-carboxyaminoimidazole ribonucleotide synthase (purK)
Ask
View Details MBS1126944-04 0.1 mg (Yeast)
Recombinant Mycobacterium leprae N5-carboxyaminoimidazole ribonucleotide synthase (purK)
Ask
View Details